World Health Organization Raises Warning Over Critical Scarcity of Weight-Loss Medications
Fewer than 10% of individuals eligible to benefit from GLP-1 drugs like Wegovy are able to get them, states the World Health Organization as it releases its first recommendations on the drugs.
Given in excess of 1,000,000,000 individuals worldwide now classified as obese, it is urging more widespread and fairer availability to these injectable treatments.
According to projections, in excess of 2,000,000,000 will be obese by 2030 without intervention.
"The new guidelines acknowledges that excess weight is a long-term condition that can be managed with thorough and ongoing treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
High costs, constrained manufacturing, and supply-chain constraints are significant hurdles to universal availability to the injections that can help people shift significant body mass, notes the agency.
Skinny Jab Scarcity
Even in the present best projected case, the manufacturing of GLP-1 therapies would only suffice for about 100 million people – fewer than 10% of eligible patients, per the health organization.
The guideline encourages nations and manufacturers to increase access, by measures like patent sharing.
The intellectual property rights on the active ingredient – the primary component of the drug Wegovy – is scheduled to end in a number of countries in 2026.
The Way Obesity Drugs Operate
These medications replicate a body's own hormone to reduce digestion speed, suppress the appetite and enhance feelings of fullness so individuals reduce food intake.
Individuals commonly begin shedding pounds after several weeks of commencing the weekly injections.
Studies suggests users may see weight return a year later of discontinuing the medication, because their usual hunger come back.
To be above a healthy weight elevates your risk for experiencing medical conditions, like diabetes, cardiovascular issues, brain attack, and certain malignancies.
Excess weight affects individuals in every country and was linked to over three and a half million deaths worldwide in 2024, per the WHO.
